Results 1 - 10
of
212
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- J. Comput. Chem
"... and multithreading ..."
A hierarchical framework for cross-domain mapreduce execution
- in Proceedings of the second international workshop on Emerging computational methods for the life sciences, ser. ECMLS ’11
"... The MapReduce programming model provides an easy way to execute pleasantly parallel applications. Many data-intensive life science applications fit this programming model and benefit from the scalability that can be delivered using this model. One such application is AutoDock, which consists of a su ..."
Abstract
-
Cited by 11 (3 self)
- Add to MetaCart
(Show Context)
The MapReduce programming model provides an easy way to execute pleasantly parallel applications. Many data-intensive life science applications fit this programming model and benefit from the scalability that can be delivered using this model. One such application is AutoDock, which consists of a suite of automated tools for predicting the bound conformations of flexible ligands to macromolecular targets. However, researchers also need sufficient computation and storage resources to fully enjoy the benefit of MapReduce. For example, a typical AutoDock based virtual screening experiment usually consists of a very large number of docking processes from multiple ligands and is often time consuming to run on a single MapReduce cluster. Although commercial clouds can provide virtually unlimited computation and storage resources on-demand, due to financial, security and
A: Docking, synthesis, and in vitro evaluation of antimitotic Estrone analogs. Chem Biol Drug Des 2011
"... In the present study, Autodock 4.0 was employed to discover potential carbonic anhydrase IX inhibitors that are able to interfere with microtubule dynamics by binding to the Colchicine binding site of tubulin. Modifications at position 2¢ of estrone were made to include moieties that are known to i ..."
Abstract
-
Cited by 9 (2 self)
- Add to MetaCart
(Show Context)
In the present study, Autodock 4.0 was employed to discover potential carbonic anhydrase IX inhibitors that are able to interfere with microtubule dynamics by binding to the Colchicine binding site of tubulin. Modifications at position 2¢ of estrone were made to include moieties that are known to improve the antimitotic activity of estradiol analogs. 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10),15-tetraen-3-ol-17-one estronem (C9) and 2-ethyl-3-Osulphamoyl-estra-1,3,5(10)16-tetraene (C12) were synthesized and tested in vitro. Growth studies were conducted utilizing spectrophotometrical analysis with crystal violet as DNA stain. Compounds C9 and C12 were cytotoxic in MCF-7 and MDA-MB-231 tumorigenic and metastatic breast cancer cells, SNO non-keratinizing squamous epithelium cancer cells and HeLa cells after 48 h exposure. Compounds C9 inhibited cell proliferation to 50% of the vehicle-treated controls from 110 to 160 nM and C12 at concentrations ranging from 180 to 220 nM. Confocal microscopy revealed abnormal spindle morphology in mitotic cells. Cell cycle analysis showed an increase in the number of cells in the G 2 /M fraction after 24 h and an increase in the number of cell in the sub-G 1 fraction after 48 h, indicating that the compounds are antimitotic and able to induce apoptosis.
Use of natural products as chemical library for drug discovery and network pharmacology
- PLoS ONE
, 2013
"... Background: Natural products have been an important source of lead compounds for drug discovery. How to find and evaluate bioactive natural products is critical to the achievement of drug/lead discovery from natural products. Methodology: We collected 19,7201 natural products structures, reported bi ..."
Abstract
-
Cited by 6 (2 self)
- Add to MetaCart
(Show Context)
Background: Natural products have been an important source of lead compounds for drug discovery. How to find and evaluate bioactive natural products is critical to the achievement of drug/lead discovery from natural products. Methodology: We collected 19,7201 natural products structures, reported biological activities and virtual screening results. Principal component analysis was employed to explore the chemical space, and we found that there was a large portion of overlap between natural products and FDA-approved drugs in the chemical space, which indicated that natural products had large quantity of potential lead compounds. We also explored the network properties of natural product-target networks and found that polypharmacology was greatly enriched to those compounds with large degree and high betweenness centrality. In order to make up for a lack of experimental data, high throughput virtual screening was employed. All natural products were docked to 332 target proteins of FDA-approved drugs. The most potential natural products for drug discovery and their indications were predicted based on a docking score-weighted prediction model. Conclusions: Analysis of molecular descriptors, distribution in chemical space and biological activities of natural products was conducted in this article. Natural products have vast chemical diversity, good drug-like properties and can interact with multiple cellular target proteins.
doi:10.1093/nar/gkq503 Opal web services for biomedical applications
, 2010
"... Biomedical applications have become increasingly complex, and they often require large-scale highperformance computing resources with a large number of processors and memory. The complexity of application deployment and the advances in cluster, grid and cloud computing require new modes of support f ..."
Abstract
-
Cited by 4 (0 self)
- Add to MetaCart
(Show Context)
Biomedical applications have become increasingly complex, and they often require large-scale highperformance computing resources with a large number of processors and memory. The complexity of application deployment and the advances in cluster, grid and cloud computing require new modes of support for biomedical research. Scientific Software as a Service (sSaaS) enables scalable and transparent access to biomedical applications through simple standards-based Web interfaces. Towards this end, we built a production web server
PERSPECTIVE Activating Mutations in TOR Are in Similar Structures As Oncogenic Mutations in PI3KC�
"... Discovery programs for cancer therapy are intently in pursuit of drugs to inhibit the class I phosphoinositide-3-OH-kinase (PI3K) and target of rapamycin (TOR) protein kinase (1). PI3K and TOR activate PKB (also known as Akt) in response to growth factors (2, 3). PI3K induces PDK1 to phosphorylate t ..."
Abstract
-
Cited by 4 (0 self)
- Add to MetaCart
(Show Context)
Discovery programs for cancer therapy are intently in pursuit of drugs to inhibit the class I phosphoinositide-3-OH-kinase (PI3K) and target of rapamycin (TOR) protein kinase (1). PI3K and TOR activate PKB (also known as Akt) in response to growth factors (2, 3). PI3K induces PDK1 to phosphorylate the activation loop of PKB (Thr308). TOR, in TOR complex 2, phosphorylates Ser473 in the C-terminal hydrophobic motif of PKB (3). Active PKB in turn switches on growth and survival pathways (1). TOR complex 1, activated in response to growth factors and nutrients, also contributes to cell growth by phosphorylating the translation regulators S6K and 4E-BP. Genetic abnormalities in cancers frequently result in activation of PKB, by loss of the tumor suppressor PTEN or by activating mutations
Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis
"... Background: The farnesoid-x-receptor (FXR) is a bile acid sensor expressed in the liver and gastrointestinal tract. Despite FXR ligands are under investigation for treatment of cholestasis, a biochemical condition occurring in a number of liver diseases for which available therapies are poorly effec ..."
Abstract
-
Cited by 4 (2 self)
- Add to MetaCart
(Show Context)
Background: The farnesoid-x-receptor (FXR) is a bile acid sensor expressed in the liver and gastrointestinal tract. Despite FXR ligands are under investigation for treatment of cholestasis, a biochemical condition occurring in a number of liver diseases for which available therapies are poorly effective, mice harboring a disrupted FXR are protected against liver injury caused by bile acid overload in rodent models of cholestasis. Theonellasterol is a 4-methylene-24-ethylsteroid isolated from the marine sponge Theonella swinhoei. Here, we have characterized the activity of this theonellasterol on FXR-regulated genes and biological functions. Principal Findings: Interrogation of HepG2 cells, a human hepatocyte cell line, by microarray analysis and transactivation assay shows that theonellasterol is a selective FXR antagonist, devoid of any agonistic or antagonistic activity on a number of human nuclear receptors including the vitamin D receptor, PPARs, PXR, LXRs, progesterone, estrogen, glucorticoid and thyroid receptors, among others. Exposure of HepG2 cells to theonellasterol antagonizes the effect of natural and synthetic FXR agonists on FXR-regulated genes, including SHP, OSTa, BSEP and MRP4. A proof-of-concept study carried out to investigate whether FXR antagonism rescues mice from liver injury caused by the ligation of the common bile duct, a model of obstructive cholestasis, demonstrated that theonellasterol attenuates injury caused by bile duct ligation as measured by assessing serum alanine aminostrasferase levels and extent of liver necrosis at histopathology. Analysis of genes involved in
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med 16: 308–312
, 2010
"... Osteoporosis is a low bone mass disease most often caused by an increase in bone resorption not compensated by a similar hike in bone formation1. Since gut–derived serotonin (GDS) inhibits bone formation2, we asked whether hampering its biosynthesis could treat osteoporosis through an anabolic mecha ..."
Abstract
-
Cited by 4 (0 self)
- Add to MetaCart
Osteoporosis is a low bone mass disease most often caused by an increase in bone resorption not compensated by a similar hike in bone formation1. Since gut–derived serotonin (GDS) inhibits bone formation2, we asked whether hampering its biosynthesis could treat osteoporosis through an anabolic mechanism. To that end we synthesized and used LP533401, a small molecule inhibitor of Tph1, the initial enzyme in GDS biosynthesis. Oral administration once daily for up to 6 weeks of this small molecule prevents the development of and fully rescues, in a dose–dependent manner, osteoporosis in ovariectomized rodents because of an isolated increase in bone formation. These results provide a proof of principle that inhibiting GDS biosynthesis could become a novel anabolic treatment for osteoporosis. Gut-derived serotonin (GDS) is a powerful inhibitor of osteoblast proliferation and bone formation that does not affect bone resorption2. Thus inhibiting GDS biosynthesis could be a Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
Atomic-Level Characterization of the Activation Mechanism of SERCA by Calcium
"... We have performed molecular dynamics (MD) simulations to elucidate, in atomic detail, the mechanism by which the sarcoplasmic reticulum Ca 2+-ATPase (SERCA) is activated by Ca 2+. Crystal structures suggest that activation of SERCA occurs when the cytoplasmic head-piece, in an open (E1) conformation ..."
Abstract
-
Cited by 4 (0 self)
- Add to MetaCart
(Show Context)
We have performed molecular dynamics (MD) simulations to elucidate, in atomic detail, the mechanism by which the sarcoplasmic reticulum Ca 2+-ATPase (SERCA) is activated by Ca 2+. Crystal structures suggest that activation of SERCA occurs when the cytoplasmic head-piece, in an open (E1) conformation stabilized by Ca 2+, undergoes a large-scale open-to-closed (E1 to E2) transition that is induced by ATP binding. However, spectroscopic measurements in solution suggest that these structural states (E1 and E2) are not tightly coupled to biochemical states (defined by bound ligands); the closed E2 state predominates even in the absence of ATP, in both the presence and absence of Ca 2+. How is this loose coupling consistent with the high efficiency of energy transduction in the Ca 2+-ATPase? To provide insight into this question, we performed long (500 ns) all-atom MD simulations starting from the open crystal structure, including a lipid bilayer and water. In both the presence and absence of Ca 2+, we observed a large-scale open-to-closed conformational transition within 400 ns, supporting the weak coupling between structural and biochemical states. However, upon closer inspection, it is clear that Ca 2+ is necessary and sufficient for SERCA to reach the precise geometrical arrangement necessary for activation of ATP hydrolysis. Contrary to suggestions from crystal structures, but in agreement with solution spectroscopy, the presence of ATP is not required for this activating transition. Principal component analysis showed that Ca 2+ reshapes the free energy landscape of SERCA to create a path between the open conformation and the activated closed conformation. Thus the
Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor
- Toxicol. Sci
, 2011
"... Phthalates and other endocrine-disruptive chemicals are manufactured in large quantities for use as plasticizers and other commercial applications, resulting in ubiquitous human exposure and thus, concern regarding their toxicity. Innate defense against small molecule exposures is controlled in lar ..."
Abstract
-
Cited by 4 (1 self)
- Add to MetaCart
(Show Context)
Phthalates and other endocrine-disruptive chemicals are manufactured in large quantities for use as plasticizers and other commercial applications, resulting in ubiquitous human exposure and thus, concern regarding their toxicity. Innate defense against small molecule exposures is controlled in large part by the constitutive androstane receptor (CAR) and the pregnane X receptor (PXR). The human CAR gene undergoes multiple alternative splicing events resulting in the CAR2 and CAR3 variant receptors. Recent studies from our laboratory show that CAR2 is potently and specifically activated by di(2-ethylhexyl) phthalate (DEHP). We hypothesized that alternative splicing is a mechanism for increasing CAR's functional diversity, broadening the human receptors' repertoire of response to environmental xenobiotics. In these studies, we examine the interaction of alternatively spliced CARs and PXR with a range of suspected endocrine disruptors, including phthalates, bisphenol A (BPA), and 4-N-nonylphenol (NP). Transactivation and two-hybrid studies in COS-1 cells revealed differential selectivity of endocrine-disrupting chemicals for the variant CAR and PXR. Ex vivo studies showed DEHP and di-isononyl phthalate potently induced CYP2B6 and CYP3A4 expression in human hepatocytes. Mutation analysis of CAR2, in silico modeling, and ligand docking studies suggested that the SPTV amino acid insertion of CAR2 creates a unique ligand-binding pocket. Alternative gene splicing results in variant CAR receptors that selectively recognize phthalates and BPA. The interaction of phthalates with CAR and PXR suggests a xenobiotic response that is complex and biologically redundant.